Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis.

ABSTRACT:

Background

While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospitalized for COVID-19 had improved outcomes compared to non-users.

Methods

We conducted a retrospective analysis of 1831 patients admitted to two medical centers in Southern California with a diagnosis of COVID-19. We evaluated outcomes including NIH COVID-19 Severity Score, need for supplemental oxygen, ICU (intensive care unit) admission, mechanical ventilation, length of hospitalization, and in-hospital death for cannabis users and non-users. Cannabis use was reported in the patient's social history. Propensity matching was used to account for differences in a

SUBMITTER: Shover CM 

PROVIDER: S-EPMC9356466 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature